420 related articles for article (PubMed ID: 17204542)
1. Concurrent duodenal manometric and impedance recording to evaluate the effects of hyoscine on motility and flow events, glucose absorption, and incretin release.
Chaikomin R; Wu KL; Doran S; Jones KL; Smout AJ; Renooij W; Holloway RH; Meyer JH; Horowitz M; Rayner CK
Am J Physiol Gastrointest Liver Physiol; 2007 Apr; 292(4):G1099-104. PubMed ID: 17204542
[TBL] [Abstract][Full Text] [Related]
2. Effects of metoclopramide on duodenal motility and flow events, glucose absorption, and incretin hormone release in response to intraduodenal glucose infusion.
Kuo P; Bellon M; Wishart J; Smout AJ; Holloway RH; Fraser RJ; Horowitz M; Jones KL; Rayner CK
Am J Physiol Gastrointest Liver Physiol; 2010 Dec; 299(6):G1326-33. PubMed ID: 20829521
[TBL] [Abstract][Full Text] [Related]
3. Effects of physiological hyperglycemia on duodenal motility and flow events, glucose absorption, and incretin secretion in healthy humans.
Kuo P; Wishart JM; Bellon M; Smout AJ; Holloway RH; Fraser RJ; Horowitz M; Jones KL; Rayner CK
J Clin Endocrinol Metab; 2010 Aug; 95(8):3893-900. PubMed ID: 20501683
[TBL] [Abstract][Full Text] [Related]
4. Effects of intraluminal local anesthetic on upper gastrointestinal motor, sensory, and peptide hormone responses to intraduodenal glucose.
Chaikomin R; Jones KL; Feinle-Bisset C; Meyer JH; Horowitz M; Rayner CK
Eur J Gastroenterol Hepatol; 2009 Mar; 21(3):258-65. PubMed ID: 19279470
[TBL] [Abstract][Full Text] [Related]
5. Small intestinal glucose absorption and duodenal motility in type 1 diabetes mellitus.
Rayner CK; Schwartz MP; van Dam PS; Renooij W; de Smet M; Horowitz M; Smout AJ; Samsom M
Am J Gastroenterol; 2002 Dec; 97(12):3123-30. PubMed ID: 12492199
[TBL] [Abstract][Full Text] [Related]
6. The release of GLP-1 and ghrelin, but not GIP and CCK, by glucose is dependent upon the length of small intestine exposed.
Little TJ; Doran S; Meyer JH; Smout AJ; O'Donovan DG; Wu KL; Jones KL; Wishart J; Rayner CK; Horowitz M; Feinle-Bisset C
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E647-55. PubMed ID: 16684852
[TBL] [Abstract][Full Text] [Related]
7. Initially more rapid small intestinal glucose delivery increases plasma insulin, GIP, and GLP-1 but does not improve overall glycemia in healthy subjects.
Chaikomin R; Doran S; Jones KL; Feinle-Bisset C; O'Donovan D; Rayner CK; Horowitz M
Am J Physiol Endocrinol Metab; 2005 Sep; 289(3):E504-7. PubMed ID: 15886226
[TBL] [Abstract][Full Text] [Related]
8. The Glucagon-Like Peptide 1 Receptor Agonist Exenatide Inhibits Small Intestinal Motility, Flow, Transit, and Absorption of Glucose in Healthy Subjects and Patients With Type 2 Diabetes: A Randomized Controlled Trial.
Thazhath SS; Marathe CS; Wu T; Chang J; Khoo J; Kuo P; Checklin HL; Bound MJ; Rigda RS; Crouch B; Jones KL; Horowitz M; Rayner CK
Diabetes; 2016 Jan; 65(1):269-75. PubMed ID: 26470783
[TBL] [Abstract][Full Text] [Related]
9. Load-dependent effects of duodenal glucose on glycemia, gastrointestinal hormones, antropyloroduodenal motility, and energy intake in healthy men.
Pilichiewicz AN; Chaikomin R; Brennan IM; Wishart JM; Rayner CK; Jones KL; Smout AJ; Horowitz M; Feinle-Bisset C
Am J Physiol Endocrinol Metab; 2007 Sep; 293(3):E743-53. PubMed ID: 17609258
[TBL] [Abstract][Full Text] [Related]
10. Effects of mid-jejunal compared to duodenal glucose infusion on peptide hormone release and appetite in healthy men.
Chaikomin R; Wu KL; Doran S; Meyer JH; Jones KL; Feinle-Bisset C; Horowitz M; Rayner CK
Regul Pept; 2008 Oct; 150(1-3):38-42. PubMed ID: 18396340
[TBL] [Abstract][Full Text] [Related]
11. Accelerated intestinal glucose absorption in morbidly obese humans: relationship to glucose transporters, incretin hormones, and glycemia.
Nguyen NQ; Debreceni TL; Bambrick JE; Chia B; Wishart J; Deane AM; Rayner CK; Horowitz M; Young RL
J Clin Endocrinol Metab; 2015 Mar; 100(3):968-76. PubMed ID: 25423571
[TBL] [Abstract][Full Text] [Related]
12. Effects of intraduodenal hydroxycitrate on glucose absorption, incretin release, and glycemia in response to intraduodenal glucose infusion in health and type 2 diabetes: A randomised controlled trial.
Thazhath SS; Wu T; Bound MJ; Checklin HL; Standfield S; Jones KL; Horowitz M; Rayner CK
Nutrition; 2016 May; 32(5):553-9. PubMed ID: 26792024
[TBL] [Abstract][Full Text] [Related]
13. The stimulation of antral motility by erythromycin is attenuated by hyperglycemia.
Rayner CK; Su YC; Doran SM; Jones KL; Malbert CH; Horowitz M
Am J Gastroenterol; 2000 Sep; 95(9):2233-41. PubMed ID: 11007223
[TBL] [Abstract][Full Text] [Related]
14. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
Svendsen PF; Nilas L; Madsbad S; Holst JJ
Metabolism; 2009 May; 58(5):586-93. PubMed ID: 19375579
[TBL] [Abstract][Full Text] [Related]
15. Comparative effects of variations in duodenal glucose load on glycemic, insulinemic, and incretin responses in healthy young and older subjects.
Trahair LG; Horowitz M; Rayner CK; Gentilcore D; Lange K; Wishart JM; Jones KL
J Clin Endocrinol Metab; 2012 Mar; 97(3):844-51. PubMed ID: 22238398
[TBL] [Abstract][Full Text] [Related]
16. Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP.
Theodorakis MJ; Carlson O; Michopoulos S; Doyle ME; Juhaszova M; Petraki K; Egan JM
Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E550-9. PubMed ID: 16219666
[TBL] [Abstract][Full Text] [Related]
17. The incretin hormones GIP and GLP-1 in diabetic rats: effects on insulin secretion and small bowel motility.
Edholm T; Cejvan K; Abdel-Halim SM; Efendic S; Schmidt PT; Hellström PM
Neurogastroenterol Motil; 2009 Mar; 21(3):313-21. PubMed ID: 19126188
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of small intestinal burst activity in the postprandial state differentially affects lipid and glucose absorption in healthy adult humans.
Bryant LK; Fraser RJ; Vozzo R; Zacharakis B; Matthews GM; Butler R
Am J Physiol Gastrointest Liver Physiol; 2004 Nov; 287(5):G1028-34. PubMed ID: 15191881
[TBL] [Abstract][Full Text] [Related]
19. Transient, early release of glucagon-like peptide-1 during low rates of intraduodenal glucose delivery.
Kuo P; Chaikomin R; Pilichiewicz A; O'Donovan D; Wishart JM; Meyer JH; Jones KL; Feinle-Bisset C; Horowitz M; Rayner CK
Regul Pept; 2008 Feb; 146(1-3):1-3. PubMed ID: 17964673
[TBL] [Abstract][Full Text] [Related]
20. Effect of the artificial sweetener, sucralose, on small intestinal glucose absorption in healthy human subjects.
Ma J; Chang J; Checklin HL; Young RL; Jones KL; Horowitz M; Rayner CK
Br J Nutr; 2010 Sep; 104(6):803-6. PubMed ID: 20420761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]